Evidence map›Paper›PMID 33390897›Full record

ReviewFrontiers in neuroscience2020

Degeneration-Dependent Retinal Remodeling: Looking for the Molecular Trigger.

Michael Telias, Scott Nawy, Richard H Kramer

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Longitudinal Structure-Function Evaluation in a Patient withDiagnostics (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michael TeliasDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, United States.
Scott NawyDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, United States.
Richard H KramerDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, United States.
University of California, Berkeley · US

Funding

UC Berkeley Vision Science COREP30EY003176 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI RICHARD H KRAMER · 1985 to 2026
$16.4M
Photoswitchable channel blockers for treatment of blindnessR24EY023937 · NEI · UNIVERSITY OF WASHINGTON · PI VAN GELDER, RUSSELL N. · 2014 to 2018
$6.1M
Understanding how photoswitches restore visual function in blindnessR01EY024334 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI KRAMER, RICHARD H · 2015 to 2024
$4.4M
NEI NIH HHS P30 EY003176NEI NIH HHS R01 EY024334NEI NIH HHS R24 EY023937
6 · The paper itself

Abstract

Vision impairment and blindness in humans are most frequently caused by the degeneration and loss of photoreceptor cells in the outer retina, as is the case for age-related macular degeneration, retinitis pigmentosa, retinal detachment and many other diseases. While inner retinal neurons survive degeneration, they undergo fundamental pathophysiological changes, collectively known as "remodeling." Inner retinal remodeling downstream to photoreceptor death occurs across mammalian retinas from mice to humans, independently of the cause of degeneration. It results in pervasive spontaneous hyperactivity and membrane hyperpermeability in retinal ganglion cells, which funnel all retinal signals to the brain. Remodeling reduces light detection in vision-impaired patients and precludes meaningful vision restoration in blind individuals. In this review, we summarize current hypotheses proposed to explain remodeling and their potential medical significance highlighting the important role played by retinoic acid and its receptor.

Indexed as

age-related macular degenerationretinal degenerationretinal ganglion cellretinal remodelingretinitis pigmentosaretinoic acidsynaptic plasticity

Identifiers

PMID33390897
PMCPMC7775662
OpenAlexW3115661454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.